tiprankstipranks
Trending News
More News >
Clearside Biomedical (CLSD)
NASDAQ:CLSD
US Market
Advertisement

Clearside Biomedical (CLSD) Income Statement

Compare
1,076 Followers

Clearside Biomedical Income Statement

Last quarter (Q2 2025), Clearside Biomedical's total revenue was $492.00K, an increase of 446.67% from the same quarter last year. In Q2, Clearside Biomedical's net income was $-4.50M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.66M$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit
$ 1.51M$ 7.87M$ 1.12M$ 29.57M$ 7.89M
Operating Expenses
$ 30.40M$ 32.72M$ 31.40M$ 30.20M$ 25.83M
Depreciation and Amortization
$ 226.00K$ 67.00K$ 145.00K$ 178.00K$ 180.00K
EBITDA
$ -24.35M$ -23.06M$ -29.46M$ 554.00K$ -17.70M
Operating Income
$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
Other Income/Expenses
$ -5.47M$ -7.64M$ -2.67M$ 1.00M$ -275.00K
Pretax Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Net Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Per Share Metrics
Basic EPS
$ -7.05$ -7.95$ -8.25$ 0.10$ -5.85
Diluted EPS
$ -7.05$ -7.95$ -8.25$ 0.09$ -5.85
Weighted Average Shares Outstanding
4.92M 4.12M 4.01M 3.90M 3.10M
Weighted Average Shares Outstanding (Diluted)
4.92M 4.12M 4.01M 3.99M 3.10M
Currency in USD

Clearside Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis